| Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy M Cecconi, D Piovani, E Brunetta, A Aghemo, M Greco, M Ciccarelli, ... Journal of clinical medicine 9 (5), 1548, 2020 | 214 | 2020 |
| Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche, M Tokuyama, ... Gastroenterology 160 (7), 2435-2450. e34, 2021 | 184* | 2021 |
| Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience F D’amico, TL Parigi, G Fiorino, L Peyrin-Biroulet, S Danese Therapeutic advances in gastroenterology 12, 1756284819848631, 2019 | 79 | 2019 |
| COVID-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy A Aghemo, D Piovani, TL Parigi, E Brunetta, N Pugliese, E Vespa, ... Clinical Gastroenterology and Hepatology 18 (10), 2366-2368. e3, 2020 | 65 | 2020 |
| PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical … X Gui, A Bazarova, R Del Amor, M Vieth, G De Hertogh, V Villanacci, ... Gut 71 (5), 889-898, 2022 | 62 | 2022 |
| Blockade of IL-23: What is in the Pipeline? TL Parigi, M Iacucci, S Ghosh Journal of Crohn's and Colitis 16 (Supplement_2), ii64-ii72, 2022 | 42 | 2022 |
| Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis M Iacucci, TL Parigi, R Del Amor, P Meseguer, G Mandelli, A Bozzola, ... Gastroenterology 164 (7), 1180-1188. e2, 2023 | 31 | 2023 |
| A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis M Iacucci, R Cannatelli, TL Parigi, OM Nardone, GE Tontini, N Labarile, ... Endoscopy 55 (04), 332-341, 2023 | 23 | 2023 |
| Variability in adenoma detection rate in control groups of randomized colonoscopy trials: a systematic review and meta-analysis C Hassan, D Piovani, M Spadaccini, T Parigi, K Khalaf, A Facciorusso, ... Gastrointestinal Endoscopy 97 (2), 212-225. e7, 2023 | 22 | 2023 |
| Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel … L Guillo, M Abreu, R Panaccione, WJ Sandborn, VF Azevedo, L Gensler, ... The Lancet Gastroenterology & Hepatology 7 (3), 254-261, 2022 | 20 | 2022 |
| Upadacitinib for Crohn’s disease and ulcerative colitis treatment: hitting the selective JAKpot TL Parigi, F D’Amico, S Danese Gastroenterology, 2020 | 19 | 2020 |
| Artificial intelligence and inflammatory bowel disease: Where are we going? L Da Rio, M Spadaccini, TL Parigi, R Gabbiadini, A Dal Buono, A Busacca, ... World Journal of Gastroenterology 29 (3), 508, 2023 | 18 | 2023 |
| Difficult-to-treat inflammatory bowel disease: Results from an international consensus meeting TL Parigi, F D'Amico, MT Abreu, A Dignass, I Dotan, F Magro, AM Griffiths, ... The Lancet Gastroenterology & Hepatology, 2023 | 17 | 2023 |
| Computer-aided imaging analysis of probe-based confocal laser endomicroscopy with molecular labeling and gene expression identifies markers of response to biological therapy in … M Iacucci, L Jeffery, A Acharjee, E Grisan, A Buda, OM Nardone, ... Inflammatory Bowel Diseases 29 (9), 1409-1420, 2023 | 15 | 2023 |
| Constrained multiple instance learning for ulcerative colitis prediction using histological images R Del Amor, P Meseguer, TL Parigi, V Villanacci, A Colomer, L Launet, ... Computer methods and programs in biomedicine 224, 107012, 2022 | 13 | 2022 |
| Evolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13 TL Parigi, F D’Amico, L Peyrin-Biroulet, S Danese Expert Opinion on Biological Therapy 21 (1), 37-46, 2021 | 12 | 2021 |
| Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure TL Parigi, MCP Torres, A Aghemo Clinical and Molecular Hepatology 25 (4), 360, 2019 | 12 | 2019 |
| Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo L Massimino, O Palmieri, A Facoetti, D Fuggetta, S Spanò, LA Lamparelli, ... Gut 72 (10), 1838-1847, 2023 | 11 | 2023 |
| Defining difficult-to-treat inflammatory bowel disease: Why and how S Danese, TL Parigi, L Peyrin-Biroulet, S Ghosh The Lancet Gastroenterology & Hepatology 6 (7), 520-522, 2021 | 11 | 2021 |
| Long-term safety of approved biologics for ulcerative colitis F D’Amico, TL Parigi, S Bonovas, L Peyrin-Biroulet, S Danese Expert Opinion on Drug Safety 19 (7), 807-816, 2020 | 11 | 2020 |
Silvio DaneseOspedale San RaffaeleEmail verificata su hsr.it
